United States · Series C startup
5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding recordSEC filing: $5.6M sold, first sale Feb 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale Mar 2012
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Sept 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Founders Fund
Schooner Capital
Western Technology Investment
Sound VenturesMax LevchinJames Hong
OS FundMissing a round, or an investor who was in one? Tell us.
Emerald Therapeutics's investors include Founders Fund, Schooner Capital, Western Technology Investment, Sound Ventures and Max Levchin, and 2 more on record.
Emerald Therapeutics has raised $40M across 5 rounds since 2010.
Emerald Therapeutics's most recent round was a Series C of $21M in Jun 2015.
Its most recent round, $21M in Jun 2015, is also its largest on record.
Emerald Therapeutics's first round on record, in Jan 2010, was backed by James Hong.
Emerald Therapeutics's latest named round is a Series C, in Jun 2015.
Emerald Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·